Robin Tranchant
23 works · 442 citations · h-index 5
Top works
- Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
- Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
- Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2 , in Malignant Pleural Mesothelioma
- Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
- Assessment of signaling pathway inhibitors and identification of predictive biomarkers in malignant pleural mesothelioma
- Hétérogénéité moléculaire des mésothéliomes pleuraux malins
- Abstract 112: Genetic alterations in molecular tumor subgroups of malignant pleural mesothelioma
- Abstract 3666: Co-occurring mutations of tumors suppressor genes, NF2 and LATS2, in malignant pleural mesothelioma
- Supplementary Tables S1-S5 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Supplementary Material and Methods from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Legends of Supplementary Figures from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Exploration fonctionnelle des mutations des gènes suppresseurs de tumeur, NF2 et LATS2, deux membres de la voie hippo, dans le mésothéliome pleural humain
- Data from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Data from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Data from Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
- Supplementary Tables S1-S5 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Supplementary Figures S1-S7 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Supplementary Material and Methods from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Supplementary Figures S1-S7 from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma
- Legends of Supplementary Figures from Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma